Stocks and Investing Stocks and Investing
Sun, October 24, 2021
Fri, October 22, 2021

Emmanuel Papadakis Initiated (BNTX) at Hold and Held Target at $250 on, Oct 22nd, 2021


Published on 2024-10-27 18:17:30 - WOPRAI, Emmanuel Papadakis
  Print publication without navigation


Emmanuel Papadakis of Deutsche Bank, Initiated "BioNTech SE" (BNTX) at Hold and Held Target at $250 on, Oct 22nd, 2021.

Emmanuel has made no other calls on BNTX in the last 4 months.



There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 4 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Akash Tewari of "Jefferies" Initiated at Hold and Held Target at $230 on, Thursday, October 7th, 2021
  • Daina Graybosch of "SVB Leerink" Maintained at Hold with Decreased Target to $268 on, Tuesday, October 5th, 2021
  • Eliana Merle of "UBS" Maintained at Hold with Increased Target to $300 on, Friday, August 27th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $330 on, Wednesday, August 11th, 2021


These are the ratings of the 2 analyists that currently disagree with Emmanuel


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $450 on, Friday, August 20th, 2021
  • Olga Smolentseva of "Bryan Garnier" Upgraded from Hold to Strong Buy and Held Target at $451 on, Wednesday, August 11th, 2021

Contributing Sources